antibodies
This New Antibody Drug Could Slow Down Cancer
PRL3-zumab, an antibody drug targeting a protein in cancer cells, has shown safety and efficacy in clinical trials.
Supporting Safe And Efficient Work With cPass™ Testing
GenScript’s cPass serology test helped one construction firm, AcroMeta Group, ensure employees could make informed decisions on their individual COVID-19 risk and prevention.
Key Antibody Targets Of SARS-CoV-2 Identified
Researchers in Hong Kong have discovered that focusing on antibodies against ORF3b and ORF8 could lead to a rapid antibody test that is both highly sensitive and specific.
Test Detects SARS-CoV-2 Neutralizing Antibodies In Hours
Not only is it much faster than conventional tests, it does not need to be performed in special biosafety laboratories.
Protective Antibodies Against COVID-19 Isolated & Characterized
Potent neutralizing antibodies from COVID-19 patients have been isolated and characterized in two separate studies from China.
A*STAR’s Chief Scientist On COVID-19 Immunity And Antibody Drugs (VIDEO)
Catch Sir David Lane, A*STAR’s Chief Scientist and leading antibody expert, in our upcoming Wildtype Media Expert Opinion webinar.
Advancing Antibody Research
Powerful antibody engineering technologies and a culture of collaboration set Chugai Pharmabody Research apart, says CEO Dr. Tomoyuki Igawa.
‘Frankenbodies’ Light Up Live Cells
A research group in Japan has created hybrid antibodies that can bind to and label specific targets in living cells.
Neutralizing Antibody Shields Mice From Zika Virus
A single injection of a human neutralizing antibody is enough to protect developing mouse embryos against Zika virus infection and microcephaly, researchers say.
Universal Antibody Drug Against HIV Developed
Hong Kong scientists have developed a bispecific antibody that ‘kills two birds with one stone’ and can neutralize virtually all known strains of HIV.
